CIK 0000875045
- Large accelerated filer
BIOGEN INC.
Sign in to watch- Ticker
- BIIB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330112644
- Phone
- +1 617-679-2000
- Business address
- 225 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-15 | PAPADOPOULOS STELIOS Director | Grant or award | +2,255 | 10,095 | ||
| 2021-07-01 | PAPADOPOULOS STELIOS Director | Grant or award | +1,275 | 7,840 | ||
| 2020-06-03 | PAPADOPOULOS STELIOS Director | Grant or award | +1,470 | 6,565 | ||
| 2019-06-19 | PAPADOPOULOS STELIOS Director | Grant or award | +1,905 | 5,095 | ||
| 2018-06-12 | PAPADOPOULOS STELIOS Director | Grant or award | +1,450 | 3,190 |
Page 1 of 1 · 5 trades